IPP Bureau
USFDA approves Rinvoq for ulcerative colitis
By IPP Bureau - March 17, 2022
First approved in 2019, Rinvoq is a JAK inhibitor approved for four indications across gastroenterology, dermatology and rheumatology
USFDA EUA for point-of-care Covid-19 rapid PCR test
By IPP Bureau - March 17, 2022
DASH enables non-laboratory personnel to insert a nasal swab specimen directly into our test cartridge and then load the cartridge into the DASH instrument, providing an accurate result in about 15 minutes
Lynparza reduced risk of death by 32% in the adjuvant treatment of patients with breast cancer
By IPP Bureau - March 17, 2022
First PARP inhibitor to demonstrate overall survival benefit in early breast cancer
Agilent establishes Centre for Excellence at Gujarat Technological University
By IPP Bureau - March 17, 2022
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
BASF and Beyond Suncare renew their cooperation to protect people with albinism in Africa
By IPP Bureau - March 17, 2022
Over the next three years, BASF will continue to support Beyond Suncare by supplying the required raw materials free of charge and by providing technical expertise to further improve the formulation
Beghou Consulting strengthens advanced analytics and data science team in Pune
By IPP Bureau - March 17, 2022
Since 1993, Beghou Consulting has helped life sciences companies - especially emerging pharmaceutical companies - establish and manage commercial operations to better market and sell therapies
Department of Pharmaceuticals release code to regulate medical devices sector
By IPP Bureau - March 17, 2022
If the government feels that the industry is not complying with the uniform code, it will consider making it a statutory code
Biological E gears up for new phase of vaccination drive
By IPP Bureau - March 17, 2022
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
Zen hospital opens dedicated cancer facility
By IPP Bureau - March 16, 2022
According to the Indian Council of Medical Research (ICMR), there will be an estimated 12 % rise in cancer cases in India in the next five years
Philips Capsule surveillance receives USFDA clearance
By IPP Bureau - March 16, 2022
Clinical surveillance solution is designed to identify emergent patient deterioration and offer enhanced patient data visibility, flexible viewing options, and clinical decision support
Nipah survivors study to advance new vaccines against highly fatal threat
By IPP Bureau - March 16, 2022
CEPI will expand its partnership with icddr,b in Bangladesh, providing near to the additional US $ 1 million in funding to advance understanding of the Nipah virus
Sapio announces the first web-based bioanalysis LIMS solution
By IPP Bureau - March 16, 2022
This pre-packaged release is a ready-to-go solution with powerful, straightforward bioanalysis pipeline support
Experts call for capacity building to combat Antimicrobial Resistance
By IPP Bureau - March 16, 2022
The meeting was co-organized by World Health Organization’s Country Office for India, World Animal Protection India and ReAct Asia Pacific
Unichem receives ANDA approval for hypertension drug
By IPP Bureau - March 16, 2022
Nebivolol is used alone or together with other medicines to treat high blood pressure
Wockhardt’s novel antibiotic Phase 1 trial to be conducted by NIH, USA
By IPP Bureau - March 16, 2022
The USFDA has granted a qualified infectious disease product (QIDP) designation to WCK 6777, which signifies its ability to meet unmet medical needs and facilitates a faster approval process
